Virginia Retirement Systems
DNLI icon

Virginia Retirement Systems’s Denali Therapeutics DNLI Stock Holding History

Virginia Retirement Systems’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$998K Buy
48,300
+34,000
+238% +$796K 0.01% 731
2026
Q2 		$368K Buy
+14,300
New +$294K ﹤0.01% 1067
2023
Q3 		$239K Buy
11,600
+1,200
+12% +$30.4K ﹤0.01% 849
2023
Q2 		$307K Sell
10,400
-3,300
-24% -$92.8K ﹤0.01% 834
2023
Q1 		$316K Buy
13,700
+1,000
+8% +$27.5K ﹤0.01% 863
2022
Q4 		$353K Sell
12,700
-300
-2% -$8.93K ﹤0.01% 921
2022
Q3 		$399K Buy
+13,000
New +$423K ﹤0.01% 864
2022
Q1 		$470K Sell
14,600
-11,100
-43% -$382K ﹤0.01% 864
2021
Q4 		$1.15M Sell
25,700
-2,900
-10% -$137K 0.01% 626
2021
Q3 		$1.44M Buy
28,600
+6,400
+29% +$361K 0.01% 504
2021
Q2 		$1.74M Buy
22,200
+1,600
+8% +$99K 0.02% 468
2021
Q1 		$1.18M Buy
20,600
+14,800
+255% +$991K 0.01% 599
2020
Q4 		$486K Sell
5,800
-8,100
-58% -$490K 0.01% 851
2020
Q3 		$498K Buy
+13,900
New +$419K 0.01% 772

Other funds holding DNLI

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Virginia Retirement Systems's DNLI Position: Q3 2026 in Review

Virginia Retirement Systems increased its Denali Therapeutics (DNLI) stake by 238% in Q3 2026, buying an estimated $796K and bringing the position to 48,300 shares worth $998K. The position accounts for 0.01% of the portfolio, ranked #731.

Virginia Retirement Systems first reported a position in DNLI in Q3 2020 and has held it in 14 quarters since. The position peaked at $1.74M in Q2 2021. 217 funds tracked by Wall St. Rank hold DNLI as of Q3 2026.

  • Virginia Retirement Systems held 48,300 shares of Denali Therapeutics worth $998K as of Q3 2026.
  • Virginia Retirement Systems bought 34,000 Denali Therapeutics shares in Q3 2026, an estimated $796K.
  • Denali Therapeutics made up 0.01% of Virginia Retirement Systems's portfolio in Q3 2026, its #731 holding.
  • Virginia Retirement Systems first reported a position in Denali Therapeutics in Q3 2020 and has held it in 14 quarters since.
  • Virginia Retirement Systems's Denali Therapeutics position peaked at $1.74M in Q2 2021.
  • 217 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2026.

Based on Virginia Retirement Systems's 13F filing for Q3 2026, filed 28 Oct 2026.